| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | aspartic-type endopeptidase activity | ERVK-18 ERVK-6 ERVK-19 ERVK-7 ERVK-21 ERVK-25 ERVK-10 ERVK-24 | 4.44e-17 | 37 | 24 | 8 | GO:0004190 |
| GeneOntologyMolecularFunction | aspartic-type peptidase activity | ERVK-18 ERVK-6 ERVK-19 ERVK-7 ERVK-21 ERVK-25 ERVK-10 ERVK-24 | 5.62e-17 | 38 | 24 | 8 | GO:0070001 |
| GeneOntologyMolecularFunction | structural molecule activity | ERVK-18 ERVK-6 COL6A1 COL21A1 COL6A2 ERVK-19 COL27A1 ERVK-7 ERVK-21 ERVK-25 ERVK-10 ERVK-24 | 9.54e-11 | 891 | 24 | 12 | GO:0005198 |
| GeneOntologyMolecularFunction | endopeptidase activity | ERVK-18 ERVK-6 ERVK-19 ERVK-7 ERVK-21 ERVK-25 ERVK-10 ERVK-24 | 2.36e-08 | 430 | 24 | 8 | GO:0004175 |
| GeneOntologyMolecularFunction | RNA-DNA hybrid ribonuclease activity | 2.50e-07 | 11 | 24 | 3 | GO:0004523 | |
| GeneOntologyMolecularFunction | extracellular matrix structural constituent conferring tensile strength | 2.53e-07 | 46 | 24 | 4 | GO:0030020 | |
| GeneOntologyMolecularFunction | RNA-directed DNA polymerase activity | 5.50e-07 | 14 | 24 | 3 | GO:0003964 | |
| GeneOntologyMolecularFunction | peptidase activity | ERVK-18 ERVK-6 ERVK-19 ERVK-7 ERVK-21 ERVK-25 ERVK-10 ERVK-24 | 5.86e-07 | 654 | 24 | 8 | GO:0008233 |
| GeneOntologyMolecularFunction | RNA stem-loop binding | 2.00e-06 | 21 | 24 | 3 | GO:0035613 | |
| GeneOntologyMolecularFunction | RNA endonuclease activity, producing 5'-phosphomonoesters | 1.15e-05 | 37 | 24 | 3 | GO:0016891 | |
| GeneOntologyMolecularFunction | DNA polymerase activity | 1.25e-05 | 38 | 24 | 3 | GO:0034061 | |
| GeneOntologyMolecularFunction | endonuclease activity, active with either ribo- or deoxyribonucleic acids and producing 5'-phosphomonoesters | 2.24e-05 | 46 | 24 | 3 | GO:0016893 | |
| GeneOntologyMolecularFunction | extracellular matrix structural constituent | 6.98e-05 | 188 | 24 | 4 | GO:0005201 | |
| GeneOntologyMolecularFunction | RNA endonuclease activity | 1.14e-04 | 79 | 24 | 3 | GO:0004521 | |
| GeneOntologyMolecularFunction | catalytic activity, acting on DNA | 2.50e-04 | 262 | 24 | 4 | GO:0140097 | |
| GeneOntologyMolecularFunction | D-mannose binding | 4.77e-04 | 27 | 24 | 2 | GO:0005537 | |
| GeneOntologyMolecularFunction | zinc ion binding | 5.23e-04 | 891 | 24 | 6 | GO:0008270 | |
| GeneOntologyMolecularFunction | RNA nuclease activity | 5.63e-04 | 136 | 24 | 3 | GO:0004540 | |
| GeneOntologyMolecularFunction | endonuclease activity | 5.63e-04 | 136 | 24 | 3 | GO:0004519 | |
| GeneOntologyMolecularFunction | nucleotidyltransferase activity | 7.78e-04 | 152 | 24 | 3 | GO:0016779 | |
| GeneOntologyMolecularFunction | transition metal ion binding | 2.34e-03 | 1189 | 24 | 6 | GO:0046914 | |
| GeneOntologyMolecularFunction | nuclease activity | 2.58e-03 | 231 | 24 | 3 | GO:0004518 | |
| GeneOntologyMolecularFunction | collagen binding | 4.23e-03 | 81 | 24 | 2 | GO:0005518 | |
| GeneOntologyMolecularFunction | monosaccharide binding | 5.77e-03 | 95 | 24 | 2 | GO:0048029 | |
| GeneOntologyMolecularFunction | catalytic activity, acting on a nucleic acid | 6.85e-03 | 645 | 24 | 4 | GO:0140640 | |
| GeneOntologyMolecularFunction | transcription coregulator binding | 1.22e-02 | 140 | 24 | 2 | GO:0001221 | |
| GeneOntologyMolecularFunction | catalytic activity, acting on RNA | 1.32e-02 | 417 | 24 | 3 | GO:0140098 | |
| GeneOntologyMolecularFunction | hydrolase activity, acting on ester bonds | 1.48e-02 | 807 | 24 | 4 | GO:0016788 | |
| GeneOntologyBiologicalProcess | DNA integration | 2.99e-07 | 13 | 22 | 3 | GO:0015074 | |
| GeneOntologyBiologicalProcess | viral process | 6.89e-06 | 464 | 22 | 6 | GO:0016032 | |
| GeneOntologyBiologicalProcess | DNA synthesis involved in DNA repair | 1.77e-05 | 48 | 22 | 3 | GO:0000731 | |
| GeneOntologyBiologicalProcess | positive regulation of opsonization | 3.89e-05 | 9 | 22 | 2 | GO:1903028 | |
| GeneOntologyBiologicalProcess | regulation of opsonization | 5.94e-05 | 11 | 22 | 2 | GO:1903027 | |
| GeneOntologyBiologicalProcess | complement activation, lectin pathway | 7.12e-05 | 12 | 22 | 2 | GO:0001867 | |
| GeneOntologyBiologicalProcess | DNA biosynthetic process | 7.65e-05 | 218 | 22 | 4 | GO:0071897 | |
| GeneOntologyBiologicalProcess | RNA-templated DNA biosynthetic process | 9.16e-05 | 83 | 22 | 3 | GO:0006278 | |
| GeneOntologyBiologicalProcess | cell-cell fusion | 9.83e-05 | 85 | 22 | 3 | GO:0140253 | |
| GeneOntologyBiologicalProcess | syncytium formation by plasma membrane fusion | 9.83e-05 | 85 | 22 | 3 | GO:0000768 | |
| GeneOntologyBiologicalProcess | syncytium formation | 1.13e-04 | 89 | 22 | 3 | GO:0006949 | |
| GeneOntologyBiologicalProcess | nucleobase-containing compound transport | 1.28e-04 | 249 | 22 | 4 | GO:0015931 | |
| GeneOntologyBiologicalProcess | opsonization | 1.84e-04 | 19 | 22 | 2 | GO:0008228 | |
| GeneOntologyBiologicalProcess | tricarboxylic acid cycle | 6.33e-04 | 35 | 22 | 2 | GO:0006099 | |
| GeneOntologyBiologicalProcess | anatomical structure formation involved in morphogenesis | 6.38e-04 | 1483 | 22 | 7 | GO:0048646 | |
| GeneOntologyBiologicalProcess | RNA transport | 8.21e-04 | 175 | 22 | 3 | GO:0050658 | |
| GeneOntologyBiologicalProcess | nucleic acid transport | 8.21e-04 | 175 | 22 | 3 | GO:0050657 | |
| GeneOntologyBiologicalProcess | establishment of RNA localization | 8.62e-04 | 178 | 22 | 3 | GO:0051236 | |
| GeneOntologyBiologicalProcess | DNA-templated DNA replication | 8.62e-04 | 178 | 22 | 3 | GO:0006261 | |
| GeneOntologyBiologicalProcess | lung cell differentiation | 9.11e-04 | 42 | 22 | 2 | GO:0060479 | |
| GeneOntologyBiologicalProcess | lung epithelial cell differentiation | 9.11e-04 | 42 | 22 | 2 | GO:0060487 | |
| GeneOntologyBiologicalProcess | phagocytosis, recognition | 9.11e-04 | 42 | 22 | 2 | GO:0006910 | |
| GeneOntologyBiologicalProcess | cell redox homeostasis | 9.55e-04 | 43 | 22 | 2 | GO:0045454 | |
| GeneOntologyCellularComponent | collagen trimer | 5.93e-10 | 88 | 24 | 6 | GO:0005581 | |
| GeneOntologyCellularComponent | endoplasmic reticulum lumen | 3.25e-05 | 332 | 24 | 5 | GO:0005788 | |
| GeneOntologyCellularComponent | serine-type endopeptidase complex | 2.37e-04 | 20 | 24 | 2 | GO:1905370 | |
| GeneOntologyCellularComponent | serine-type peptidase complex | 2.88e-04 | 22 | 24 | 2 | GO:1905286 | |
| GeneOntologyCellularComponent | collagen-containing extracellular matrix | 2.90e-03 | 530 | 24 | 4 | GO:0062023 | |
| HumanPheno | Hip dislocation | 1.32e-06 | 263 | 9 | 6 | HP:0002827 | |
| HumanPheno | Abnormality of the elbow | 1.99e-06 | 282 | 9 | 6 | HP:0009811 | |
| HumanPheno | Lower extremity joint dislocation | 4.04e-06 | 318 | 9 | 6 | HP:0030311 | |
| HumanPheno | Limited elbow movement | 4.16e-06 | 168 | 9 | 5 | HP:0002996 | |
| HumanPheno | Joint dislocation | 1.34e-05 | 390 | 9 | 6 | HP:0001373 | |
| HumanPheno | Hyperlordosis | 1.64e-05 | 222 | 9 | 5 | HP:0003307 | |
| HumanPheno | Lordosis | 1.64e-05 | 222 | 9 | 5 | HP:0002939 | |
| HumanPheno | Reduced maximal expiratory pressure | 1.66e-05 | 4 | 9 | 2 | HP:0012497 | |
| HumanPheno | Reduced muscle collagen VI | 1.66e-05 | 4 | 9 | 2 | HP:0030095 | |
| HumanPheno | Curved toe phalanx | 1.66e-05 | 4 | 9 | 2 | HP:0010176 | |
| HumanPheno | Increased laxity of fingers | 2.77e-05 | 5 | 9 | 2 | HP:0006149 | |
| HumanPheno | Keratosis pilaris | 2.88e-05 | 37 | 9 | 3 | HP:0032152 | |
| HumanPheno | Caudal appendage | 4.15e-05 | 6 | 9 | 2 | HP:0002825 | |
| HumanPheno | Prominent coccyx | 4.15e-05 | 6 | 9 | 2 | HP:0040016 | |
| HumanPheno | Abnormal hip joint morphology | 5.02e-05 | 490 | 9 | 6 | HP:0001384 | |
| HumanPheno | Wrist hypermobility | 5.80e-05 | 7 | 9 | 2 | HP:0005072 | |
| HumanPheno | Abnormal synovial membrane morphology | 5.83e-05 | 503 | 9 | 6 | HP:0005262 | |
| HumanPheno | Abnormal coccyx morphology | 9.93e-05 | 9 | 9 | 2 | HP:0008519 | |
| HumanPheno | Cigarette-paper scars | 1.24e-04 | 10 | 9 | 2 | HP:0001073 | |
| HumanPheno | Abnormality of the wrist | 1.26e-04 | 168 | 9 | 4 | HP:0003019 | |
| HumanPheno | Telecanthus | 1.42e-04 | 173 | 9 | 4 | HP:0000506 | |
| HumanPheno | Limited pronation/supination of forearm | 1.51e-04 | 11 | 9 | 2 | HP:0006394 | |
| HumanPheno | Large fleshy ears | 2.14e-04 | 13 | 9 | 2 | HP:0002265 | |
| HumanPheno | Abnormal hip bone morphology | 2.59e-04 | 653 | 9 | 6 | HP:0003272 | |
| HumanPheno | Muscle fiber necrosis | 2.88e-04 | 15 | 9 | 2 | HP:0003713 | |
| HumanPheno | Epicanthus inversus | 2.88e-04 | 15 | 9 | 2 | HP:0000537 | |
| HumanPheno | Diaphragmatic weakness | 3.72e-04 | 17 | 9 | 2 | HP:0009113 | |
| HumanPheno | Torticollis | 3.75e-04 | 87 | 9 | 3 | HP:0000473 | |
| HumanPheno | Abnormality of upper limb joint | 3.98e-04 | 705 | 9 | 6 | HP:0009810 | |
| HumanPheno | Limitation of joint mobility | 4.05e-04 | 432 | 9 | 5 | HP:0001376 | |
| HumanPheno | Abnormal pelvic girdle bone morphology | 4.84e-04 | 730 | 9 | 6 | HP:0002644 | |
| HumanPheno | Lumbar hyperlordosis | 5.49e-04 | 99 | 9 | 3 | HP:0002938 | |
| HumanPheno | Abnormal cranial suture/fontanelle morphology | 6.15e-04 | 472 | 9 | 5 | HP:0000235 | |
| HumanPheno | Quadriceps muscle weakness | 6.89e-04 | 23 | 9 | 2 | HP:0003731 | |
| HumanPheno | Dermal atrophy | 6.90e-04 | 107 | 9 | 3 | HP:0004334 | |
| HumanPheno | Progressive proximal muscle weakness | 9.52e-04 | 27 | 9 | 2 | HP:0009073 | |
| HumanPheno | Craniofacial dystonia | 1.04e-03 | 123 | 9 | 3 | HP:0012179 | |
| HumanPheno | Diastasis recti | 1.10e-03 | 29 | 9 | 2 | HP:0001540 | |
| HumanPheno | Blepharophimosis | 1.19e-03 | 129 | 9 | 3 | HP:0000581 | |
| HumanPheno | Abnormal muscle fiber protein expression | 1.34e-03 | 32 | 9 | 2 | HP:0030089 | |
| HumanPheno | Congenital hypothyroidism | 1.34e-03 | 32 | 9 | 2 | HP:0000851 | |
| HumanPheno | Increased endomysial connective tissue | 1.34e-03 | 32 | 9 | 2 | HP:0100297 | |
| HumanPheno | Frequent falls | 1.48e-03 | 139 | 9 | 3 | HP:0002359 | |
| HumanPheno | Focal dystonia | 1.48e-03 | 139 | 9 | 3 | HP:0004373 | |
| HumanPheno | Synostosis involving bones of the upper limbs | 1.51e-03 | 140 | 9 | 3 | HP:0100238 | |
| HumanPheno | Atrophic scars | 1.79e-03 | 37 | 9 | 2 | HP:0001075 | |
| HumanPheno | Wrist flexion contracture | 1.89e-03 | 38 | 9 | 2 | HP:0001239 | |
| HumanPheno | Abnormality of the lower urinary tract | 1.93e-03 | 937 | 9 | 6 | HP:0010936 | |
| HumanPheno | Increased muscle lipid content | 2.09e-03 | 40 | 9 | 2 | HP:0009058 | |
| Domain | Collagen | 5.89e-13 | 85 | 17 | 7 | PF01391 | |
| Domain | Collagen | 5.89e-13 | 85 | 17 | 7 | IPR008160 | |
| Domain | VWA | 1.69e-05 | 56 | 17 | 3 | PF00092 | |
| Domain | - | 3.90e-05 | 74 | 17 | 3 | 3.40.50.410 | |
| Domain | VWFA | 5.31e-05 | 82 | 17 | 3 | PS50234 | |
| Domain | VWA | 5.70e-05 | 84 | 17 | 3 | SM00327 | |
| Domain | VWF_A | 9.31e-05 | 99 | 17 | 3 | IPR002035 | |
| Domain | TSPN | 1.95e-04 | 23 | 17 | 2 | SM00210 | |
| Domain | C-type_lectin_CS | 6.89e-04 | 43 | 17 | 2 | IPR018378 | |
| Domain | Laminin_G | 1.25e-03 | 58 | 17 | 2 | IPR001791 | |
| Domain | C_TYPE_LECTIN_1 | 2.36e-03 | 80 | 17 | 2 | PS00615 | |
| Domain | Lectin_C | 2.60e-03 | 84 | 17 | 2 | PF00059 | |
| Domain | CLECT | 2.60e-03 | 84 | 17 | 2 | SM00034 | |
| Domain | C_TYPE_LECTIN_2 | 2.66e-03 | 85 | 17 | 2 | PS50041 | |
| Domain | C-type_lectin-like | 2.72e-03 | 86 | 17 | 2 | IPR001304 | |
| Domain | - | 3.45e-03 | 97 | 17 | 2 | 3.10.100.10 | |
| Domain | C-type_lectin-like/link | 3.59e-03 | 99 | 17 | 2 | IPR016186 | |
| Domain | CTDL_fold | 4.18e-03 | 107 | 17 | 2 | IPR016187 | |
| Domain | ConA-like_dom | 1.66e-02 | 219 | 17 | 2 | IPR013320 | |
| Pathway | REACTOME_COLLAGEN_CHAIN_TRIMERIZATION | 8.08e-08 | 44 | 14 | 4 | M27812 | |
| Pathway | REACTOME_COLLAGEN_BIOSYNTHESIS_AND_MODIFYING_ENZYMES | 4.50e-07 | 67 | 14 | 4 | M26999 | |
| Pathway | REACTOME_COLLAGEN_FORMATION | 1.48e-06 | 90 | 14 | 4 | M631 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_SARS_COV_2_S_N_TO_LECTIN_PATHWAY_OF_COAGULATION_CASCADE | 1.37e-05 | 6 | 14 | 2 | M47785 | |
| Pathway | REACTOME_LECTIN_PATHWAY_OF_COMPLEMENT_ACTIVATION | 1.92e-05 | 7 | 14 | 2 | MM14654 | |
| Pathway | KEGG_MEDICUS_REFERENCE_LECTIN_PATHWAY_OF_COAGULATION_CASCADE_PROTHROMBIN_TO_THROMBIN | 2.56e-05 | 8 | 14 | 2 | M47784 | |
| Pathway | REACTOME_LECTIN_PATHWAY_OF_COMPLEMENT_ACTIVATION | 2.56e-05 | 8 | 14 | 2 | M27005 | |
| Pathway | REACTOME_ASSEMBLY_OF_COLLAGEN_FIBRILS_AND_OTHER_MULTIMERIC_STRUCTURES | 2.71e-05 | 61 | 14 | 3 | M27103 | |
| Pathway | KEGG_MEDICUS_REFERENCE_LECTIN_PATHWAY_OF_COAGULATION_CASCADE_FIBRINOGEN_TO_FIBRIN | 4.10e-05 | 10 | 14 | 2 | M47879 | |
| Pathway | KEGG_MEDICUS_REFERENCE_LECTIN_PATHWAY_OF_COMPLEMENT_CASCADE_C4_C2_TO_C3_CONVERTASE_FORMATION | 5.01e-05 | 11 | 14 | 2 | M47874 | |
| Pathway | REACTOME_SCAVENGING_BY_CLASS_A_RECEPTORS | 1.55e-04 | 19 | 14 | 2 | M27221 | |
| Pathway | REACTOME_EXTRACELLULAR_MATRIX_ORGANIZATION | 1.70e-04 | 300 | 14 | 4 | M610 | |
| Pathway | REACTOME_NCAM1_INTERACTIONS | 1.72e-04 | 20 | 14 | 2 | MM15061 | |
| Pathway | REACTOME_NCAM_SIGNALING_FOR_NEURITE_OUT_GROWTH | 6.31e-04 | 38 | 14 | 2 | MM14969 | |
| Pathway | REACTOME_COLLAGEN_CHAIN_TRIMERIZATION | 7.35e-04 | 41 | 14 | 2 | MM15538 | |
| Pathway | REACTOME_NCAM1_INTERACTIONS | 7.71e-04 | 42 | 14 | 2 | M7169 | |
| Pathway | WP_MIRNA_TARGETS_IN_ECM_AND_MEMBRANE_RECEPTORS | 8.08e-04 | 43 | 14 | 2 | M39565 | |
| Pathway | PID_SYNDECAN_1_PATHWAY | 9.25e-04 | 46 | 14 | 2 | M198 | |
| Pathway | REACTOME_ECM_PROTEOGLYCANS | 9.65e-04 | 47 | 14 | 2 | MM14925 | |
| Pathway | REACTOME_ASSEMBLY_OF_COLLAGEN_FIBRILS_AND_OTHER_MULTIMERIC_STRUCTURES | 1.09e-03 | 50 | 14 | 2 | MM14796 | |
| Pathway | REACTOME_COLLAGEN_DEGRADATION | 1.23e-03 | 53 | 14 | 2 | MM14566 | |
| Pathway | REACTOME_INITIAL_TRIGGERING_OF_COMPLEMENT | 1.27e-03 | 54 | 14 | 2 | MM14655 | |
| Pathway | REACTOME_SIGNALING_BY_PDGF | 1.42e-03 | 57 | 14 | 2 | MM14713 | |
| Pathway | REACTOME_SIGNALING_BY_PDGF | 1.47e-03 | 58 | 14 | 2 | M2049 | |
| Pathway | REACTOME_COLLAGEN_BIOSYNTHESIS_AND_MODIFYING_ENZYMES | 1.62e-03 | 61 | 14 | 2 | MM14637 | |
| Pathway | REACTOME_NCAM_SIGNALING_FOR_NEURITE_OUT_GROWTH | 1.73e-03 | 63 | 14 | 2 | M11187 | |
| Pathway | REACTOME_COLLAGEN_DEGRADATION | 1.78e-03 | 64 | 14 | 2 | M26953 | |
| Pathway | PID_INTEGRIN1_PATHWAY | 1.89e-03 | 66 | 14 | 2 | M18 | |
| Pathway | REACTOME_CREATION_OF_C4_AND_C2_ACTIVATORS | 2.19e-03 | 71 | 14 | 2 | M1078 | |
| Pathway | PID_AVB3_INTEGRIN_PATHWAY | 2.37e-03 | 74 | 14 | 2 | M160 | |
| Pathway | REACTOME_ECM_PROTEOGLYCANS | 2.50e-03 | 76 | 14 | 2 | M27219 | |
| Pathway | REACTOME_COLLAGEN_FORMATION | 2.50e-03 | 76 | 14 | 2 | MM14573 | |
| Pathway | REACTOME_INTEGRIN_CELL_SURFACE_INTERACTIONS | 2.50e-03 | 76 | 14 | 2 | MM14867 | |
| Pathway | REACTOME_INITIAL_TRIGGERING_OF_COMPLEMENT | 2.77e-03 | 80 | 14 | 2 | M6121 | |
| Pathway | REACTOME_COMPLEMENT_CASCADE | 3.05e-03 | 84 | 14 | 2 | MM14653 | |
| Pathway | KEGG_ECM_RECEPTOR_INTERACTION | 3.05e-03 | 84 | 14 | 2 | M7098 | |
| Pathway | REACTOME_INTEGRIN_CELL_SURFACE_INTERACTIONS | 3.12e-03 | 85 | 14 | 2 | M16441 | |
| Pathway | REACTOME_BINDING_AND_UPTAKE_OF_LIGANDS_BY_SCAVENGER_RECEPTORS | 4.12e-03 | 98 | 14 | 2 | M27152 | |
| Pathway | REACTOME_VESICLE_MEDIATED_TRANSPORT | 4.59e-03 | 725 | 14 | 4 | M27507 | |
| Pathway | WP_COMPLEMENT_SYSTEM_IN_NEURONAL_DEVELOPMENT_AND_PLASTICITY | 4.81e-03 | 106 | 14 | 2 | M42535 | |
| Pathway | REACTOME_DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX | 5.54e-03 | 114 | 14 | 2 | MM14571 | |
| Pathway | REACTOME_COMPLEMENT_CASCADE | 5.63e-03 | 115 | 14 | 2 | M19752 | |
| Pathway | REACTOME_DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX | 8.24e-03 | 140 | 14 | 2 | M587 | |
| Pathway | REACTOME_SIGNALING_BY_RECEPTOR_TYROSINE_KINASES | 1.43e-02 | 532 | 14 | 3 | M27870 | |
| Pathway | KEGG_FOCAL_ADHESION | 1.61e-02 | 199 | 14 | 2 | M7253 | |
| Pubmed | Quantitation of HERV-K env gene expression and splicing in human breast cancer. | 1.00e-16 | 5 | 24 | 5 | 12629516 | |
| Pubmed | A revised nomenclature for transcribed human endogenous retroviral loci. | ERVK-18 ERVK-6 ERVK-19 ERVK-7 ERVK-21 ERVK-25 ERVK-10 ERVK-24 | 1.49e-15 | 94 | 24 | 8 | 21542922 |
| Pubmed | Many human endogenous retrovirus K (HERV-K) proviruses are unique to humans. | 1.74e-13 | 4 | 24 | 4 | 10469592 | |
| Pubmed | 8.54e-13 | 18 | 24 | 5 | 18664271 | ||
| Pubmed | 2.89e-10 | 3 | 24 | 3 | 10516026 | ||
| Pubmed | 1.15e-09 | 4 | 24 | 3 | 7983737 | ||
| Pubmed | 3.45e-08 | 10 | 24 | 3 | 12970426 | ||
| Pubmed | 6.33e-08 | 12 | 24 | 3 | 14557543 | ||
| Pubmed | Collagen type VI‑α1 and 2 repress the proliferation, migration and invasion of bladder cancer cells. | 4.56e-07 | 2 | 24 | 2 | 33982770 | |
| Pubmed | 4.56e-07 | 2 | 24 | 2 | 27341702 | ||
| Pubmed | 4.56e-07 | 2 | 24 | 2 | 25710878 | ||
| Pubmed | Ullrich disease due to deficiency of collagen VI in the sarcolemma. | 4.56e-07 | 2 | 24 | 2 | 14981181 | |
| Pubmed | 4.56e-07 | 2 | 24 | 2 | 30108587 | ||
| Pubmed | 4.56e-07 | 2 | 24 | 2 | 6852033 | ||
| Pubmed | 4.56e-07 | 2 | 24 | 2 | 12374585 | ||
| Pubmed | 4.56e-07 | 2 | 24 | 2 | 25912189 | ||
| Pubmed | 4.56e-07 | 2 | 24 | 2 | 9060628 | ||
| Pubmed | Novel mutations in collagen VI genes: expansion of the Bethlem myopathy phenotype. | 4.56e-07 | 2 | 24 | 2 | 11865138 | |
| Pubmed | Evolutionary relationships within a subgroup of HERV-K-related human endogenous retroviruses. | 4.56e-07 | 2 | 24 | 2 | 9460924 | |
| Pubmed | 4.56e-07 | 2 | 24 | 2 | 1765372 | ||
| Pubmed | Interferon-alpha-induced endogenous superantigen. a model linking environment and autoimmunity. | 4.56e-07 | 2 | 24 | 2 | 11672541 | |
| Pubmed | 4.56e-07 | 2 | 24 | 2 | 2551668 | ||
| Pubmed | 4.56e-07 | 2 | 24 | 2 | 19309692 | ||
| Pubmed | Mosaicism for dominant collagen 6 mutations as a cause for intrafamilial phenotypic variability. | 1.37e-06 | 3 | 24 | 2 | 25204870 | |
| Pubmed | Association of Polymorphisms of MASP1/3, COLEC10, and COLEC11 Genes with 3MC Syndrome. | 1.37e-06 | 3 | 24 | 2 | 32751929 | |
| Pubmed | 1.37e-06 | 3 | 24 | 2 | 8168508 | ||
| Pubmed | 1.37e-06 | 3 | 24 | 2 | 7780011 | ||
| Pubmed | 1.37e-06 | 3 | 24 | 2 | 20301676 | ||
| Pubmed | Type VI collagen mutations in Bethlem myopathy, an autosomal dominant myopathy with contractures. | 1.37e-06 | 3 | 24 | 2 | 8782832 | |
| Pubmed | Collagen VI involvement in Ullrich syndrome: a clinical, genetic, and immunohistochemical study. | 1.37e-06 | 3 | 24 | 2 | 12011280 | |
| Pubmed | 1.37e-06 | 3 | 24 | 2 | 21459131 | ||
| Pubmed | 1.37e-06 | 3 | 24 | 2 | 36982625 | ||
| Pubmed | Amino acid sequence of the triple-helical domain of human collagen type VI. | 1.37e-06 | 3 | 24 | 2 | 3198591 | |
| Pubmed | 1.37e-06 | 3 | 24 | 2 | 12840783 | ||
| Pubmed | 1.37e-06 | 3 | 24 | 2 | 3665927 | ||
| Pubmed | 1.37e-06 | 3 | 24 | 2 | 8489506 | ||
| Pubmed | Exon skipping mutations in collagen VI are common and are predictive for severity and inheritance. | 1.37e-06 | 3 | 24 | 2 | 18366090 | |
| Pubmed | 1.37e-06 | 3 | 24 | 2 | 24443028 | ||
| Pubmed | Dominant collagen VI mutations are a common cause of Ullrich congenital muscular dystrophy. | 1.37e-06 | 3 | 24 | 2 | 15563506 | |
| Pubmed | Spatial and temporal changes of type VI collagen expression during mouse development. | 1.37e-06 | 3 | 24 | 2 | 8853993 | |
| Pubmed | 1.37e-06 | 3 | 24 | 2 | 24801232 | ||
| Pubmed | Expression of type VI collagen in the developing mouse heart. | 1.37e-06 | 3 | 24 | 2 | 9520112 | |
| Pubmed | 1.37e-06 | 3 | 24 | 2 | 16141002 | ||
| Pubmed | 1.37e-06 | 3 | 24 | 2 | 32053901 | ||
| Pubmed | 1.37e-06 | 3 | 24 | 2 | 17602442 | ||
| Pubmed | Cloning and chromosomal localization of human genes encoding the three chains of type VI collagen. | 1.37e-06 | 3 | 24 | 2 | 3348212 | |
| Pubmed | 2.74e-06 | 4 | 24 | 2 | 18761340 | ||
| Pubmed | 2.74e-06 | 4 | 24 | 2 | 1544908 | ||
| Pubmed | 2.74e-06 | 4 | 24 | 2 | 8806434 | ||
| Pubmed | 2.74e-06 | 4 | 24 | 2 | 26154564 | ||
| Pubmed | 2.74e-06 | 4 | 24 | 2 | 24174618 | ||
| Pubmed | Deficiency of tenascin-X causes a decrease in the level of expression of type VI collagen. | 2.74e-06 | 4 | 24 | 2 | 15194424 | |
| Pubmed | Transcriptionally active HERV-K genes: identification, isolation, and chromosomal mapping. | 4.56e-06 | 5 | 24 | 2 | 11401426 | |
| Pubmed | Physical mapping of mouse collagen genes on chromosome 10 by high-resolution FISH. | 4.56e-06 | 5 | 24 | 2 | 11331940 | |
| Pubmed | 4.56e-06 | 5 | 24 | 2 | 1837533 | ||
| Pubmed | The expanded collagen VI family: new chains and new questions. | 4.56e-06 | 5 | 24 | 2 | 23869615 | |
| Pubmed | 6.83e-06 | 6 | 24 | 2 | 8812475 | ||
| Pubmed | 6.83e-06 | 6 | 24 | 2 | 15063128 | ||
| Pubmed | Developmental regulation of biglycan expression in muscle and tendon. | 6.83e-06 | 6 | 24 | 2 | 16810681 | |
| Pubmed | Three novel collagen VI chains with high homology to the alpha3 chain. | 9.56e-06 | 7 | 24 | 2 | 18276594 | |
| Pubmed | Type VI collagen anchors endothelial basement membranes by interacting with type IV collagen. | 9.56e-06 | 7 | 24 | 2 | 9334230 | |
| Pubmed | Three novel collagen VI chains, alpha4(VI), alpha5(VI), and alpha6(VI). | 9.56e-06 | 7 | 24 | 2 | 18400749 | |
| Pubmed | Fras1 deficiency results in cryptophthalmos, renal agenesis and blebbed phenotype in mice. | 1.27e-05 | 8 | 24 | 2 | 12766770 | |
| Pubmed | The extracellular matrix gene Frem1 is essential for the normal adhesion of the embryonic epidermis. | 2.05e-05 | 10 | 24 | 2 | 15345741 | |
| Pubmed | Mutations in C1orf194, encoding a calcium regulator, cause dominant Charcot-Marie-Tooth disease. | 2.50e-05 | 11 | 24 | 2 | 31199454 | |
| Pubmed | A collagen VI-dependent pathogenic mechanism for Hirschsprung's disease. | 3.00e-05 | 12 | 24 | 2 | 26571399 | |
| Pubmed | Proteomics characterization of extracellular space components in the human aorta. | 4.60e-05 | 101 | 24 | 3 | 20551380 | |
| Pubmed | 5.44e-05 | 16 | 24 | 2 | 16880404 | ||
| Pubmed | Genetic loci that control vascular endothelial growth factor-induced angiogenesis. | 6.17e-05 | 17 | 24 | 2 | 12958152 | |
| Pubmed | 6.17e-05 | 17 | 24 | 2 | 1975791 | ||
| Pubmed | 6.17e-05 | 17 | 24 | 2 | 22573622 | ||
| Pubmed | Congenital Muscular Dystrophy Overview – RETIRED CHAPTER, FOR HISTORICAL REFERENCE ONLY | 6.17e-05 | 17 | 24 | 2 | 20301468 | |
| Pubmed | Mapping HSA 3 loci in cattle: additional support for the ancestral synteny of HSA 3 and 21. | 6.94e-05 | 18 | 24 | 2 | 1783381 | |
| Pubmed | 7.75e-05 | 19 | 24 | 2 | 12435353 | ||
| Pubmed | 7.75e-05 | 19 | 24 | 2 | 29196262 | ||
| Pubmed | Characterization of the Extracellular Matrix of Normal and Diseased Tissues Using Proteomics. | 1.09e-04 | 135 | 24 | 3 | 28675934 | |
| Pubmed | 1.25e-04 | 24 | 24 | 2 | 25344368 | ||
| Pubmed | 1.36e-04 | 25 | 24 | 2 | 10051316 | ||
| Pubmed | 1.47e-04 | 26 | 24 | 2 | 38281222 | ||
| Pubmed | 1.58e-04 | 153 | 24 | 3 | 25037231 | ||
| Pubmed | 1.71e-04 | 28 | 24 | 2 | 30947518 | ||
| Pubmed | 2.04e-04 | 167 | 24 | 3 | 22159717 | ||
| Pubmed | 2.34e-04 | 175 | 24 | 3 | 28071719 | ||
| Pubmed | 2.53e-04 | 34 | 24 | 2 | 10613844 | ||
| Pubmed | 2.76e-04 | 467 | 24 | 4 | 30194290 | ||
| Pubmed | 3.16e-04 | 38 | 24 | 2 | 25572963 | ||
| Pubmed | 4.00e-04 | 210 | 24 | 3 | 16537572 | ||
| Pubmed | 4.84e-04 | 47 | 24 | 2 | 32892421 | ||
| Pubmed | 5.48e-04 | 50 | 24 | 2 | 23658023 | ||
| Pubmed | Extracellular matrix secretion by cardiac fibroblasts: role of microRNA-29b and microRNA-30c. | 6.49e-04 | 248 | 24 | 3 | 24006456 | |
| Pubmed | 6.87e-04 | 56 | 24 | 2 | 20096683 | ||
| Interaction | COLGALT2 interactions | 4.01e-11 | 67 | 20 | 6 | int:COLGALT2 | |
| Interaction | COLEC11 interactions | 8.02e-07 | 19 | 20 | 3 | int:COLEC11 | |
| Interaction | PLOD3 interactions | 8.11e-07 | 183 | 20 | 5 | int:PLOD3 | |
| Interaction | DEFB125 interactions | 9.43e-07 | 20 | 20 | 3 | int:DEFB125 | |
| Interaction | C1QTNF1 interactions | 1.32e-05 | 47 | 20 | 3 | int:C1QTNF1 | |
| Interaction | COL9A1 interactions | 7.25e-05 | 13 | 20 | 2 | int:COL9A1 | |
| Interaction | TIMP3 interactions | 9.29e-05 | 90 | 20 | 3 | int:TIMP3 | |
| Interaction | PLOD1 interactions | 1.74e-04 | 292 | 20 | 4 | int:PLOD1 | |
| Cytoband | 21q22.3 | 1.88e-03 | 128 | 23 | 2 | 21q22.3 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr21q22 | 1.52e-02 | 377 | 23 | 2 | chr21q22 | |
| GeneFamily | Collagens | 2.58e-08 | 46 | 13 | 4 | 490 | |
| GeneFamily | Collectins | 2.14e-05 | 10 | 13 | 2 | 491 | |
| GeneFamily | Hyalectan proteoglycans|V-set domain containing|Sushi domain containing|C-type lectin domain containing | 3.85e-04 | 41 | 13 | 2 | 1298 | |
| Coexpression | NABA_COLLAGENS | 1.24e-08 | 44 | 16 | 4 | M3005 | |
| Coexpression | NABA_COLLAGENS | 2.27e-06 | 43 | 16 | 3 | MM17060 | |
| Coexpression | HARRIS_BRAIN_CANCER_PROGENITORS | 2.27e-06 | 43 | 16 | 3 | M1694 | |
| Coexpression | HARRIS_BRAIN_CANCER_PROGENITORS | 2.61e-06 | 45 | 16 | 3 | MM1213 | |
| Coexpression | DESCARTES_ORGANOGENESIS_CONNECTIVE_TISSUE_PROGENITOR | 4.80e-06 | 55 | 16 | 3 | MM3666 | |
| Coexpression | GAO_LARGE_INTESTINE_ADULT_CJ_IMMUNE_CELLS | 9.54e-06 | 505 | 16 | 5 | M39167 | |
| Coexpression | NABA_CORE_MATRISOME | 1.95e-05 | 275 | 16 | 4 | M5884 | |
| Coexpression | NABA_MATRISOME | 2.03e-05 | 1026 | 16 | 6 | M5889 | |
| Coexpression | DESCARTES_FETAL_EYE_STROMAL_CELLS | 2.19e-05 | 91 | 16 | 3 | M40180 | |
| Coexpression | NIKOLSKY_BREAST_CANCER_21Q22_AMPLICON | 4.17e-05 | 16 | 16 | 2 | M5718 | |
| Coexpression | CUI_DEVELOPING_HEART_C3_FIBROBLAST_LIKE_CELL | 4.65e-05 | 117 | 16 | 3 | M39300 | |
| Coexpression | AIZARANI_LIVER_C33_STELLATE_CELLS_2 | 5.80e-05 | 126 | 16 | 3 | M39132 | |
| Coexpression | NABA_MATRISOME_BLEO_FIBROTIC_LUNG | 6.60e-05 | 20 | 16 | 2 | MM17053 | |
| Coexpression | HU_FETAL_RETINA_FIBROBLAST | 7.25e-05 | 385 | 16 | 4 | M39264 | |
| Coexpression | JACKSON_DNMT1_TARGETS_DN | 7.29e-05 | 21 | 16 | 2 | MM1196 | |
| Coexpression | MURATA_VIRULENCE_OF_H_PILORI | 8.01e-05 | 22 | 16 | 2 | M18608 | |
| Coexpression | JACKSON_DNMT1_TARGETS_DN | 8.01e-05 | 22 | 16 | 2 | M1627 | |
| Coexpression | MISHRA_CARCINOMA_ASSOCIATED_FIBROBLAST_UP | 9.57e-05 | 24 | 16 | 2 | M18292 | |
| Coexpression | CUI_TCF21_TARGETS_2_UP | 1.18e-04 | 437 | 16 | 4 | M1610 | |
| Coexpression | CUI_TCF21_TARGETS_2_UP | 1.38e-04 | 455 | 16 | 4 | MM1189 | |
| Coexpression | NABA_MATRISOME_METASTATIC_LUNG_LYMPH_NODE_METASTASIS | 1.40e-04 | 29 | 16 | 2 | MM17055 | |
| Coexpression | TSAI_RESPONSE_TO_RADIATION_THERAPY | 1.71e-04 | 32 | 16 | 2 | M308 | |
| Coexpression | BROWNE_HCMV_INFECTION_48HR_DN | 1.72e-04 | 482 | 16 | 4 | M12144 | |
| Coexpression | SCHRAETS_MLL_TARGETS_DN | 1.82e-04 | 33 | 16 | 2 | M1904 | |
| Coexpression | ROZANOV_MMP14_TARGETS_SUBSET | 1.82e-04 | 33 | 16 | 2 | M9167 | |
| Coexpression | LIU_PROSTATE_CANCER_DN | 1.88e-04 | 493 | 16 | 4 | M19391 | |
| Coexpression | CLASPER_LYMPHATIC_VESSELS_DURING_METASTASIS_DN | 2.05e-04 | 35 | 16 | 2 | M11788 | |
| Coexpression | AIZARANI_LIVER_C21_STELLATE_CELLS_1 | 2.08e-04 | 194 | 16 | 3 | M39122 | |
| Coexpression | CUI_TCF21_TARGETS_UP | 2.17e-04 | 36 | 16 | 2 | M7883 | |
| Coexpression | CLASPER_LYMPHATIC_VESSELS_DURING_METASTASIS_DN | 2.17e-04 | 36 | 16 | 2 | MM1212 | |
| Coexpression | GSE15930_NAIVE_VS_24H_IN_VITRO_STIM_CD8_TCELL_UP | 2.28e-04 | 200 | 16 | 3 | M3587 | |
| Coexpression | CUI_TCF21_TARGETS_UP | 2.30e-04 | 37 | 16 | 2 | MM1171 | |
| Coexpression | SCHRAETS_MLL_TARGETS_DN | 2.30e-04 | 37 | 16 | 2 | MM1258 | |
| Coexpression | PAL_PRMT5_TARGETS_UP | 2.41e-04 | 204 | 16 | 3 | M10688 | |
| Coexpression | NABA_MATRISOME | 2.55e-04 | 1008 | 16 | 5 | MM17056 | |
| Coexpression | PAL_PRMT5_TARGETS_UP | 2.63e-04 | 210 | 16 | 3 | MM1172 | |
| Coexpression | NABA_BASEMENT_MEMBRANES | 2.69e-04 | 40 | 16 | 2 | M5887 | |
| Coexpression | CUI_DEVELOPING_HEART_LEFT_VENTRICULAR_CARDIOMYOCYTE | 2.69e-04 | 40 | 16 | 2 | M39313 | |
| Coexpression | HAN_JNK_SINGALING_DN | 2.69e-04 | 40 | 16 | 2 | M1655 | |
| Coexpression | HAN_JNK_SINGALING_DN | 3.26e-04 | 44 | 16 | 2 | MM696 | |
| Coexpression | ZHANG_UTERUS_C2_SECRETORY_STROMAL3_RAMP3_HIGH_CELL | 3.39e-04 | 229 | 16 | 3 | MM16607 | |
| Coexpression | BURTON_ADIPOGENESIS_4 | 3.41e-04 | 45 | 16 | 2 | M1605 | |
| Coexpression | BURTON_ADIPOGENESIS_4 | 3.56e-04 | 46 | 16 | 2 | MM1187 | |
| Coexpression | TSENG_ADIPOGENIC_POTENTIAL_DN | 3.72e-04 | 47 | 16 | 2 | M8364 | |
| Coexpression | GUILLAUMOND_KLF10_TARGETS_UP | 4.21e-04 | 50 | 16 | 2 | M2485 | |
| Coexpression | TSENG_ADIPOGENIC_POTENTIAL_DN | 4.38e-04 | 51 | 16 | 2 | MM689 | |
| Coexpression | BROWNE_HCMV_INFECTION_30MIN_UP | 4.91e-04 | 54 | 16 | 2 | M6977 | |
| Coexpression | ROZANOV_MMP14_TARGETS_UP | 5.31e-04 | 267 | 16 | 3 | M12890 | |
| Coexpression | NABA_CORE_MATRISOME | 5.48e-04 | 270 | 16 | 3 | MM17057 | |
| Coexpression | GUILLAUMOND_KLF10_TARGETS_UP | 5.86e-04 | 59 | 16 | 2 | MM952 | |
| Coexpression | DESCARTES_MAIN_FETAL_STELLATE_CELLS | 6.68e-04 | 63 | 16 | 2 | M40119 | |
| Coexpression | RUBENSTEIN_SKELETAL_MUSCLE_FBN1_FAP_CELLS | 6.68e-04 | 289 | 16 | 3 | M41750 | |
| Coexpression | CUI_DEVELOPING_HEART_COMPACT_VENTRICULAR_CARDIOMYOCYTE | 7.11e-04 | 65 | 16 | 2 | M39309 | |
| Coexpression | TRAVAGLINI_LUNG_ADVENTITIAL_FIBROBLAST_CELL | 7.16e-04 | 296 | 16 | 3 | M41675 | |
| Coexpression | FAN_OVARY_CL6_PUTATIVE_EARLY_ATRETIC_FOLLICLE_THECAL_CELL_2 | 7.44e-04 | 300 | 16 | 3 | M41708 | |
| Coexpression | JECHLINGER_EPITHELIAL_TO_MESENCHYMAL_TRANSITION_UP | 7.77e-04 | 68 | 16 | 2 | M1406 | |
| Coexpression | ZHANG_UTERUS_C1_PROLIFERATIVE_STROMAL1_MGP_HIGH_CELL | 8.18e-04 | 310 | 16 | 3 | MM16608 | |
| Coexpression | GU_PDEF_TARGETS_UP | 8.47e-04 | 71 | 16 | 2 | M3955 | |
| Coexpression | FAN_OVARY_CL5_HEALTHY_SELECTABLE_FOLLICLE_THECAL_CELL | 8.81e-04 | 318 | 16 | 3 | M41707 | |
| Coexpression | TABULA_MURIS_SENIS_GONADAL_ADIPOSE_TISSUE_MYELOID_CELL_AGEING | 9.30e-04 | 324 | 16 | 3 | MM3701 | |
| Coexpression | JECHLINGER_EPITHELIAL_TO_MESENCHYMAL_TRANSITION_UP | 9.45e-04 | 75 | 16 | 2 | MM1143 | |
| Coexpression | HAY_BONE_MARROW_STROMAL | 1.00e-03 | 767 | 16 | 4 | M39209 | |
| Coexpression | ZHANG_UTERUS_C0_SECRETORY_STROMAL3_NPPC_HIGH_CELL | 1.04e-03 | 337 | 16 | 3 | MM16606 | |
| Coexpression | DURANTE_ADULT_OLFACTORY_NEUROEPITHELIUM_FIBROBLASTS_STROMAL_CELLS | 1.13e-03 | 82 | 16 | 2 | M39274 | |
| Coexpression | ZHANG_UTERUS_C4_MYOFIBROBLAST | 1.35e-03 | 369 | 16 | 3 | MM16610 | |
| Coexpression | FAN_OVARY_CL1_GPRC5A_TNFRS12A_HIGH_SELECTABLE_FOLLICLE_STROMAL_CELL | 1.47e-03 | 380 | 16 | 3 | M41703 | |
| Coexpression | LIM_MAMMARY_LUMINAL_MATURE_DN | 1.48e-03 | 94 | 16 | 2 | M2580 | |
| Coexpression | LIM_MAMMARY_LUMINAL_MATURE_DN | 1.51e-03 | 95 | 16 | 2 | MM1328 | |
| Coexpression | BLANCO_MELO_COVID19_SARS_COV_2_INFECTION_A594_ACE2_EXPRESSING_CELLS_DN | 1.54e-03 | 96 | 16 | 2 | M34017 | |
| Coexpression | FAN_OVARY_CL2_PUTATIVE_EARLY_ATRETIC_FOLLICLE_THECAL_CELL_1 | 1.60e-03 | 98 | 16 | 2 | M41704 | |
| Coexpression | HUMMERICH_SKIN_CANCER_PROGRESSION_DN | 1.77e-03 | 103 | 16 | 2 | M1170 | |
| Coexpression | REN_ALVEOLAR_RHABDOMYOSARCOMA_DN | 1.79e-03 | 407 | 16 | 3 | M19541 | |
| Coexpression | HUMMERICH_SKIN_CANCER_PROGRESSION_DN | 2.05e-03 | 111 | 16 | 2 | MM1111 | |
| Coexpression | CHARAFE_BREAST_CANCER_LUMINAL_VS_MESENCHYMAL_DN | 2.62e-03 | 465 | 16 | 3 | M9192 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_P2_bladder stroma (LCM)_emap-30396_k-means-cluster#3_top-relative-expression-ranked_1000 | 2.17e-05 | 229 | 16 | 4 | gudmap_developingLowerUrinaryTract_P2_bladder stroma (LCM)_1000_k3 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_P2_bladder stroma (LCM)_emap-30396_k-means-cluster#5_top-relative-expression-ranked_500 | 2.48e-05 | 77 | 16 | 3 | gudmap_developingLowerUrinaryTract_P2_bladder stroma (LCM)_500_k5 | |
| CoexpressionAtlas | DevelopingGonad_e18.5_testes_emap-11164_k-means-cluster#3_top-relative-expression-ranked_500 | 4.51e-05 | 94 | 16 | 3 | gudmap_developingGonad_e18.5_testes_500_k3 | |
| CoexpressionAtlas | DevelopingGonad_e18.5_testes_emap-11164_k-means-cluster#4_top-relative-expression-ranked_1000 | 5.67e-05 | 293 | 16 | 4 | gudmap_developingGonad_e18.5_testes_1000_k4 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ bladder_emap-30872_k-means-cluster#4_top-relative-expression-ranked_1000 | 1.24e-04 | 132 | 16 | 3 | gudmap_developingLowerUrinaryTract_e14.5_ bladder_1000_k4 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_P2_bladder stroma (LCM)_emap-30396_top-relative-expression-ranked_500 | 1.66e-04 | 387 | 16 | 4 | gudmap_developingLowerUrinaryTract_P2_bladder stroma (LCM)_500 | |
| CoexpressionAtlas | DevelopingGonad_e18.5_epididymis_emap-13166_k-means-cluster#4_top-relative-expression-ranked_200 | 1.85e-04 | 27 | 16 | 2 | gudmap_developingGonad_e18.5_epididymis_200_k4 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_P2_bladder stroma (LCM)_emap-30396_top-relative-expression-ranked_1000 | 2.09e-04 | 783 | 16 | 5 | gudmap_developingLowerUrinaryTract_P2_bladder stroma (LCM)_1000 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_P2_bladder stroma (LCM)_emap-30396_top-relative-expression-ranked_200 | 2.27e-04 | 162 | 16 | 3 | gudmap_developingLowerUrinaryTract_P2_bladder stroma (LCM)_200 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_P2_bladder stroma (LCM)_emap-30396_k-means-cluster#4_top-relative-expression-ranked_200 | 2.44e-04 | 31 | 16 | 2 | gudmap_developingLowerUrinaryTract_P2_bladder stroma (LCM)_200_k4 | |
| CoexpressionAtlas | Stromal Cells, Fi.Sk, gp38+ CD140a+, Skin, avg-4 | 2.65e-04 | 437 | 16 | 4 | GSM777046_500 | |
| CoexpressionAtlas | Stromal Cells, Fi.MTS15+.Th, CD45- PDGFRa+ MTS15+, Thymus, avg-3 | 2.84e-04 | 445 | 16 | 4 | GSM777043_500 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e15.5_ureteral tissue_emap-8234_k-means-cluster#5_top-relative-expression-ranked_500 | 5.64e-04 | 47 | 16 | 2 | gudmap_developingLowerUrinaryTract_e15.5_ureteral tissue_500_k5 | |
| CoexpressionAtlas | DevelopingGonad_e18.5_epididymis_emap-13166_k-means-cluster#5_top-relative-expression-ranked_1000 | 6.65e-04 | 234 | 16 | 3 | gudmap_developingGonad_e18.5_epididymis_1000_k5 | |
| CoexpressionAtlas | DevelopingGonad_e18.5_epididymis_emap-13166_k-means-cluster#2_top-relative-expression-ranked_500 | 1.04e-03 | 64 | 16 | 2 | gudmap_developingGonad_e18.5_epididymis_500_k2 | |
| CoexpressionAtlas | dev lower uro neuro_e15.5_PelvicGanglion_Sox10_k-means-cluster#3_top-relative-expression-ranked_1000 | 1.11e-03 | 66 | 16 | 2 | gudmap_dev lower uro neuro_e15.5_PelvicGanglion_Sox10_k3_1000 | |
| CoexpressionAtlas | BM Top 100 - endometrium | 1.11e-03 | 66 | 16 | 2 | BM Top 100 - endometrium | |
| CoexpressionAtlas | BM Top 100 - colon cecum | 1.18e-03 | 68 | 16 | 2 | BM Top 100 - colon cecum | |
| CoexpressionAtlas | facebase_RNAseq_e14.5_palate_poster_oral_Tgfbr2_WT_2500_K2 | 1.25e-03 | 70 | 16 | 2 | facebase_RNAseq_e14.5_palate_poster_oral_Tgfbr2_WT_2500_K2 | |
| CoexpressionAtlas | BM Top 100 - adipose tissue | 1.25e-03 | 70 | 16 | 2 | BM Top 100 - adipose tissue | |
| CoexpressionAtlas | DevelopingGonad_P2_epididymis_emap-30199_k-means-cluster#1_top-relative-expression-ranked_500 | 1.28e-03 | 71 | 16 | 2 | gudmap_developingGonad_P2_epididymis_500_k1 | |
| CoexpressionAtlas | BM Top 100 - stomach fundus | 1.28e-03 | 71 | 16 | 2 | BM Top 100 - stomach fundus | |
| CoexpressionAtlas | BM Top 100 - adipose tissue subcutaneous | 1.32e-03 | 72 | 16 | 2 | BM Top 100 - adipose tissue subcutaneous | |
| CoexpressionAtlas | BM Top 100 - coronary artery | 1.36e-03 | 73 | 16 | 2 | BM Top 100 - coronary artery | |
| CoexpressionAtlas | EB blastocyst_vs_EB amniotic fluid MSC-Confounder_removed-fold2.0_adjp0.05 | 1.36e-03 | 300 | 16 | 3 | PCBC_ratio_EB blastocyst_vs_EB amniotic fluid MSC_cfr-2X-p05 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_P2_bladder stroma (LCM)_emap-30396_top-relative-expression-ranked_100 | 1.71e-03 | 82 | 16 | 2 | gudmap_developingLowerUrinaryTract_P2_bladder stroma (LCM)_100 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ bladder_emap-30872_top-relative-expression-ranked_100 | 1.75e-03 | 83 | 16 | 2 | gudmap_developingLowerUrinaryTract_e14.5_ bladder_100 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e13.5_bladder mesenchyme_emap-3087_top-relative-expression-ranked_100 | 1.88e-03 | 86 | 16 | 2 | gudmap_developingLowerUrinaryTract_e13.5_bladder mesenchyme_100 | |
| CoexpressionAtlas | facebase_RNAseq_e14.5_palate_poster_proximal_ERK2_WT_2500_K0 | 1.96e-03 | 88 | 16 | 2 | facebase_RNAseq_e14.5_palate_poster_proximal_ERK2_WT_2500_K0 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e13.5_bladder mesenchyme_emap-3087_k-means-cluster#3_top-relative-expression-ranked_500 | 1.96e-03 | 88 | 16 | 2 | gudmap_developingLowerUrinaryTract_e13.5_bladder mesenchyme_500_k3 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ bladder_emap-6668_top-relative-expression-ranked_100 | 2.01e-03 | 89 | 16 | 2 | DevelopingLowerUrinaryTract_e14.5_ bladder_emap-6668_100 | |
| CoexpressionAtlas | DevelopingGonad_e16.5_epididymis_emap-29702_k-means-cluster#1_top-relative-expression-ranked_500 | 2.14e-03 | 92 | 16 | 2 | gudmap_developingGonad_e16.5_epididymis_500_k1 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_P1_bladder_B_emap-30374_top-relative-expression-ranked_1000 | 2.25e-03 | 774 | 16 | 4 | gudmap_developingLowerUrinaryTract_P1_bladder_1000_B | |
| CoexpressionAtlas | facebase_RNAseq_e14.5_palate_poster_nasal_Tgfbr2_WT_2500_K4 | 2.28e-03 | 95 | 16 | 2 | facebase_RNAseq_e14.5_palate_poster_nasal_Tgfbr2_WT_2500_K4 | |
| CoexpressionAtlas | Stromal Cells, Fi.MTS15+.Th, CD45- PDGFRa+ MTS15+, Thymus, avg-3 | 2.38e-03 | 97 | 16 | 2 | GSM777043_100 | |
| CoexpressionAtlas | Stromal Cells, Fi.Sk, gp38+ CD140a+, Skin, avg-4 | 2.38e-03 | 97 | 16 | 2 | GSM777046_100 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_P1_bladder_B_emap-30374_k-means-cluster#2_top-relative-expression-ranked_1000 | 2.66e-03 | 379 | 16 | 3 | gudmap_developingLowerUrinaryTract_P1_bladder_B_1000_k2 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ bladder_emap-30872_top-relative-expression-ranked_1000 | 2.66e-03 | 811 | 16 | 4 | gudmap_developingLowerUrinaryTract_e14.5_ bladder_1000 | |
| CoexpressionAtlas | DevelopingGonad_e18.5_testes_emap-11164_top-relative-expression-ranked_1000 | 2.70e-03 | 814 | 16 | 4 | gudmap_developingGonad_e18.5_testes_1000 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e15.5_ureteral tissue_emap-8234_k-means-cluster#2_top-relative-expression-ranked_1000 | 2.88e-03 | 107 | 16 | 2 | gudmap_developingLowerUrinaryTract_e15.5_ureteral tissue_1000_k2 | |
| CoexpressionAtlas | DevelopingGonad_P2_testes_emap-30171_top-relative-expression-ranked_500 | 3.27e-03 | 408 | 16 | 3 | gudmap_developingGonad_P2_testes_500 | |
| CoexpressionAtlas | DevelopingGonad_e18.5_testes_emap-11164_top-relative-expression-ranked_500 | 3.36e-03 | 412 | 16 | 3 | gudmap_developingGonad_e18.5_testes_500 | |
| CoexpressionAtlas | DevelopingGonad_P2_testes_emap-30171_k-means-cluster#2_top-relative-expression-ranked_500 | 3.43e-03 | 117 | 16 | 2 | gudmap_developingGonad_P2_testes_500_k2 | |
| CoexpressionAtlas | gudmap_RNAseq_e15.5_Mesangium_2500_K1 | 3.43e-03 | 117 | 16 | 2 | gudmap_RNAseq_e15.5_Mesangium_2500_K1 | |
| CoexpressionAtlas | geo_heart_top-relative-expression-ranked_500_k-means-cluster#2 | 3.49e-03 | 118 | 16 | 2 | geo_heart_500_K2 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e13.5_bladder mesenchyme_emap-3087_top-relative-expression-ranked_500 | 3.55e-03 | 420 | 16 | 3 | gudmap_developingLowerUrinaryTract_e13.5_bladder mesenchyme_500 | |
| CoexpressionAtlas | facebase_RNAseq_e14.5_palate_poster_distal_ERK2_WT_2500_K3 | 3.67e-03 | 121 | 16 | 2 | facebase_RNAseq_e14.5_palate_poster_distal_ERK2_WT_2500_K3 | |
| ToppCell | droplet-Lung-30m-Mesenchymal-fibroblast-adventitial_fibroblast-adventitial_fibroblast_l17|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 5.80e-09 | 193 | 16 | 5 | 64edc1d6fb0fe117767d494cf4a5723bf8be2804 | |
| ToppCell | 5'-Adult-SmallIntestine-Mesenchymal-fibroblastic-Stromal_1_(CCL11+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.59e-09 | 198 | 16 | 5 | 7582ee9ec8a87ecb094201f1f9191b412f9d2875 | |
| ToppCell | background-Hepatic_Stellate_cells|background / Sample and Cell Type and Tumor Cluster (all cells) | 6.59e-09 | 198 | 16 | 5 | bd11b0e9e80449aab979a02c1023e0638c431c7c | |
| ToppCell | Control-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.01e-07 | 125 | 16 | 4 | b162a5bfbb8ac5e65e13578fef9de442a9e4fd8b | |
| ToppCell | 367C-Fibroblasts-Fibroblast-A_(Fibroblast_progenitors)|367C / Donor, Lineage, Cell class and subclass (all cells) | 3.38e-07 | 169 | 16 | 4 | 47fd4adfe54777e69a0fabf8bd34f26223f63275 | |
| ToppCell | 367C-Fibroblasts-Fibroblast-A_(Fibroblast_progenitors)-|367C / Donor, Lineage, Cell class and subclass (all cells) | 3.38e-07 | 169 | 16 | 4 | e09259d62cd3e42f0919f231ed1164db59b0b6c3 | |
| ToppCell | Adult-Mesenchymal-airway_smooth_muscle_cell|Adult / Lineage, Cell type, age group and donor | 3.71e-07 | 173 | 16 | 4 | a5331721bd9f9a66530dd4ffe28cb3a5a8cad8fc | |
| ToppCell | 5'-Adult-SmallIntestine-Mesenchymal-fibroblastic-Stromal_3_(C7+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.06e-07 | 177 | 16 | 4 | bd602db857f37869ef76d14c05ef522c509f08ee | |
| ToppCell | 10x5'v1-week_14-16-Myeloid_macrophage-stroma-osteoclast|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 4.15e-07 | 178 | 16 | 4 | a28683690ab8a60eb18f3ef87ea85da4e95b22df | |
| ToppCell | droplet-Kidney-nan-21m-Mesenchymal-fibroblast|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.74e-07 | 184 | 16 | 4 | 3bffadb0cb2e0d825bdb6cfc5d23f5436cbc3efd | |
| ToppCell | droplet-Kidney-nan-21m-Mesenchymal-Stroma____fibroblast|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.85e-07 | 185 | 16 | 4 | 9954fc85b183c1cc45c3c24e3dadc7984ee6f649 | |
| ToppCell | droplet-Kidney-nan-21m-Mesenchymal|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.85e-07 | 185 | 16 | 4 | 33cc0e9d8b54cb7408b51235f2a70e044ebae04d | |
| ToppCell | droplet-Liver-LIVER_HEP-30m-Mesenchymal-hepatic_stellate_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.85e-07 | 185 | 16 | 4 | 40e958511790e84321da5ccf735f9974c06a0263 | |
| ToppCell | moderate-Lymphoid-NK|moderate / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 4.85e-07 | 185 | 16 | 4 | 4979a787acbc9b4ca8defe91cc79b674e51af1bf | |
| ToppCell | droplet-Liver-LIVER_HEP-30m-Mesenchymal-hepatic_stellate_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.85e-07 | 185 | 16 | 4 | 5f2eeba80aff145e85cfd81e2890a155406badb9 | |
| ToppCell | droplet-Liver-LIVER_HEP-30m-Mesenchymal|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.85e-07 | 185 | 16 | 4 | f814ec9d4ade717a0109398e9768d0d66f09317b | |
| ToppCell | 10x3'2.3-week_14-16-Myeloid_macrophage-stroma-osteoclast|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 4.85e-07 | 185 | 16 | 4 | 5ed49b6d8214c6119355a6d3ee4e25d40bcc0c53 | |
| ToppCell | facs-Limb_Muscle-Muscle_forelimb_and_hindlimb-18m-Mesenchymal-mesenchymal_stem_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.95e-07 | 186 | 16 | 4 | a7ab70b049742dfe7ee30557031bfac6412edf52 | |
| ToppCell | 3'-Adult-LargeIntestine-Mesenchymal-fibroblastic-Stromal_2_(NPY+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.95e-07 | 186 | 16 | 4 | d3509a579871ba6a8c4edd6137b28f271c9dbe70 | |
| ToppCell | droplet-Liver-HEPATOCYTES-1m-Mesenchymal|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.06e-07 | 187 | 16 | 4 | e6afbaed352310a1cb49571a2aae18be1f533c9a | |
| ToppCell | droplet-Liver-HEPATOCYTES-1m-Mesenchymal-hepatic_stellate_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.06e-07 | 187 | 16 | 4 | b6ecf55014f246461bf1ca12f24cb4d046661fa4 | |
| ToppCell | droplet-Liver-HEPATOCYTES-1m-Mesenchymal-hepatic_stellate_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.06e-07 | 187 | 16 | 4 | 9fb15f24b9b364b0c4704ec98aec236eaec5411c | |
| ToppCell | 5'-Adult-LargeIntestine-Mesenchymal-fibroblastic-Stromal_2_(NPY+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.17e-07 | 188 | 16 | 4 | 997dcfc4f08738ab398d8abc15e4fd2fc6619862 | |
| ToppCell | 10x3'2.3-week_14-16-Mesenchymal_fibro-stroma-endosteal_fibroblast|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 5.17e-07 | 188 | 16 | 4 | 0e2d1b21f0a7ee306e7dae16fc8c19d16a467883 | |
| ToppCell | IPF-Epithelial-Aberrant_Basaloid|Epithelial / Disease state, Lineage and Cell class | 5.28e-07 | 189 | 16 | 4 | 4178be3292ff4a8a1d8098f638d4b8d15164d2c6 | |
| ToppCell | 10x5'v1-week_14-16-Mesenchymal_fibro-stroma|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 5.28e-07 | 189 | 16 | 4 | eccf3d49354a67c94f1ed7c15a98a48a5e8e2ed0 | |
| ToppCell | droplet-Limb_Muscle-nan-21m-Mesenchymal-mesenchymal_stem_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.28e-07 | 189 | 16 | 4 | 56f43e00d81cf3cdf0c39f8d7120f5beab72e258 | |
| ToppCell | facs-Diaphragm-Limb_Muscle-18m-Mesenchymal-mesenchymal_stem_cell|Diaphragm / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.28e-07 | 189 | 16 | 4 | dde037322c8caec0c04c5be1c1b59a167824ad9f | |
| ToppCell | 10x5'v1-week_14-16-Mesenchymal_fibro|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 5.28e-07 | 189 | 16 | 4 | 40764f461b8aa1d3a2c5a30590b7fb9307d47d09 | |
| ToppCell | facs-Diaphragm-Limb_Muscle-24m-Mesenchymal-mesenchymal_stem_cell|Diaphragm / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.39e-07 | 190 | 16 | 4 | d13fd234caa3fc69d8a59bc0060cdacdf716ee55 | |
| ToppCell | droplet-Limb_Muscle-nan-24m-Mesenchymal-mesenchymal_stem_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.39e-07 | 190 | 16 | 4 | ad0f5605db6b694445ec9bd5dc8d2d834358c0f9 | |
| ToppCell | 10x5'v1-week_14-16-Mesenchymal_fibro-stroma-endosteal_fibroblast|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 5.50e-07 | 191 | 16 | 4 | 44b1f62fdee03b157fe545f2ae6ff84f8929a8ac | |
| ToppCell | PND07-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF2|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.50e-07 | 191 | 16 | 4 | 9f478f36a0b895e607e3bb77fa0f9f03cc0f33fc | |
| ToppCell | 10x5'v1-week_14-16-Mesenchymal_fibro-stroma-arteriolar_fibroblast|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 5.50e-07 | 191 | 16 | 4 | 5271198116343c07202649889057e5774d7fdde3 | |
| ToppCell | droplet-Fat-Gat-18m-Mesenchymal|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.50e-07 | 191 | 16 | 4 | 850c6fff6dc795431ef534fdaa41e4ad50f7367a | |
| ToppCell | droplet-Fat-Gat-18m-Mesenchymal-mesenchymal_stem_cell_of_adipose|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.50e-07 | 191 | 16 | 4 | 8b2b00202d3c98bccbae1b4a23713892fad0ff23 | |
| ToppCell | droplet-Limb_Muscle-Pre-Sort-18m-Mesenchymal-mesenchymal_stem_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.50e-07 | 191 | 16 | 4 | 1b26056df078674f37a6c06f6256b30cfcec21a7 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_2_cell|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 5.62e-07 | 192 | 16 | 4 | 8d56e360ebc624ca4cd7f0af4f3cc599c244f134 | |
| ToppCell | facs-Trachea-24m-Mesenchymal-fibroblast-fibroblast_of_trachea|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 5.62e-07 | 192 | 16 | 4 | 7a2e79490e4f7058bb76b46c45b5df9f729e3146 | |
| ToppCell | Mesenchymal-matrix_fibroblast_2_cell|World / Lineage, Cell type, age group and donor | 5.62e-07 | 192 | 16 | 4 | a769158c49d2b208c4224d85e7ae68c85cc372ed | |
| ToppCell | facs-Trachea-24m-Mesenchymal|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 5.62e-07 | 192 | 16 | 4 | e8af6ad1ae99cae13a82d0d8d7f38af9b777f0ba | |
| ToppCell | facs-Trachea-24m-Mesenchymal-fibroblast|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 5.62e-07 | 192 | 16 | 4 | fc940f91ff8e051631dbf25e6e8d73cf8337eccb | |
| ToppCell | 3'-GW_trimst-1.5-LargeIntestine-Mesenchymal-fibroblastic|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.74e-07 | 193 | 16 | 4 | 68089ba4123e2f9bea9aae0023a844b5a57bfc0e | |
| ToppCell | facs-Diaphragm-Limb_Muscle-3m-Mesenchymal-mesenchymal_stem_cell|Diaphragm / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.74e-07 | 193 | 16 | 4 | 160691b671710be10220803d788c2c961c236af1 | |
| ToppCell | PND07-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF2-AF2_mature|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.74e-07 | 193 | 16 | 4 | 051f61156b0e2e95292b2d8377faf3190b50f264 | |
| ToppCell | facs-GAT-Fat-18m-Mesenchymal-mesenchymal_progenitor|GAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.86e-07 | 194 | 16 | 4 | 9709dc95fb6982b6a0467b507845d5bc17252e3e | |
| ToppCell | facs-Kidney-nan-18m-Mesenchymal-mesangial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.86e-07 | 194 | 16 | 4 | bbc625b4cc53bb7d6254fde287258e51f9171572 | |
| ToppCell | facs-GAT-Fat-18m-Mesenchymal-mesenchymal_stem_cell_of_adipose|GAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.86e-07 | 194 | 16 | 4 | 93b7a9065430740ec31fce4e8c14ffccb498591d | |
| ToppCell | droplet-Liver-LIVER-NPC-1m-Mesenchymal-hepatic_stellate_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.86e-07 | 194 | 16 | 4 | 415801a3dfacf05f2b603fb424df3d045190a812 | |
| ToppCell | facs-Kidney-nan-18m-Mesenchymal|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.86e-07 | 194 | 16 | 4 | fcd5e9238d299c41f0bf9693b56cd8c900d2112b | |
| ToppCell | facs-GAT-Fat-18m-Mesenchymal|GAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.86e-07 | 194 | 16 | 4 | 0d2e65b44e3f143971c2fd24c4552f042b049cfa | |
| ToppCell | facs-Kidney-nan-18m-Mesenchymal-mesangial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.86e-07 | 194 | 16 | 4 | 6afc21c5fec30ab8e373e3e46ab7866204c805b6 | |
| ToppCell | droplet-Liver-LIVER-NPC-1m-Mesenchymal-hepatic_stellate_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.86e-07 | 194 | 16 | 4 | 256cb33ec90328f2704921fb0fe0fd9812e138b0 | |
| ToppCell | droplet-Liver-LIVER-NPC-1m-Mesenchymal|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.86e-07 | 194 | 16 | 4 | 7942bc83c1bdca687795b91aa232824d603f9b09 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_2_cell-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 5.86e-07 | 194 | 16 | 4 | 439d3f17c1f4736122b330e98add9292c7036a8e | |
| ToppCell | facs-Trachea-24m-Mesenchymal-fibroblast-fibroblast_of_trachea-tracheal_fibroblast_l1|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 5.86e-07 | 194 | 16 | 4 | 889c6e231bdd5b59902c7d2afdc077360b1d3256 | |
| ToppCell | droplet-Trachea-3m-Mesenchymal-myofibroblast|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 5.98e-07 | 195 | 16 | 4 | 0feb6ebe7b4b781dec7cfaef844140cfbf84b4b9 | |
| ToppCell | droplet-Trachea-3m-Mesenchymal-myofibroblast-tracheobronchial_smooth_muscle_cell|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 5.98e-07 | 195 | 16 | 4 | 2a6f67875cef140b0e6b8401436719675c6b3665 | |
| ToppCell | 10x3'2.3-week_17-19-Mesenchymal_osteo-stroma-osteoblast_precursor|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 5.98e-07 | 195 | 16 | 4 | ec12cfb2fce44cc2de4e198ef5af075e626f0329 | |
| ToppCell | Mesenchymal_cells|World / Lineage and Cell class | 5.98e-07 | 195 | 16 | 4 | 380eb436baa371f7aa2dc0c4a594afb173b5a25b | |
| ToppCell | droplet-Bladder-nan-3m-Epithelial-bladder_mesenchymal_cell_(Car3+)|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.98e-07 | 195 | 16 | 4 | 095b8e0be385b6390420589124a95fa4ba3682ab | |
| ToppCell | E17.5-Mesenchymal-myocytic_cell-aortic_smooth_muscle_cell|E17.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 5.98e-07 | 195 | 16 | 4 | 1daddd801bd4596fffbdb822fc326d5127c96004 | |
| ToppCell | facs-Lung-3m|Lung / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 5.98e-07 | 195 | 16 | 4 | c4648c0332c3826776f9ad3f5f803dbac2b4c0c0 | |
| ToppCell | 10x3'2.3-week_14-16-Mesenchymal_fibro|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 6.10e-07 | 196 | 16 | 4 | ee45e4de9d706ec87094e87f47d3e514539b8092 | |
| ToppCell | LAM-Mesenchyme|LAM / Condition, Lineage and Cell class | 6.10e-07 | 196 | 16 | 4 | e7918b0cd5eeb675012f871f43f4388471845035 | |
| ToppCell | Children_(3_yrs)-Mesenchymal|Children_(3_yrs) / Lineage, Cell type, age group and donor | 6.10e-07 | 196 | 16 | 4 | bc94909f9b2dc08a59eef1914148b69720569c8f | |
| ToppCell | facs-Trachea|facs / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.10e-07 | 196 | 16 | 4 | 34020d6553309daa269dff05de0a8567211ea4d2 | |
| ToppCell | facs-Lung-nan|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.10e-07 | 196 | 16 | 4 | b05f77f3990b662682ffeaf0e4c2fb190e0a6e65 | |
| ToppCell | 10x3'2.3-week_14-16-Mesenchymal_fibro-stroma|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 6.10e-07 | 196 | 16 | 4 | fa4a85a3cd52df0da5dfedc0e584e9df8c61ce89 | |
| ToppCell | LAM-Mesenchyme-Mesenchyme|LAM / Condition, Lineage and Cell class | 6.10e-07 | 196 | 16 | 4 | 4590fb157797a68dca4295e203702bbae279cd03 | |
| ToppCell | facs-Lung-nan-3m|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.10e-07 | 196 | 16 | 4 | 787c6cd92035e0b1108c2c086c42a229016e476b | |
| ToppCell | facs-Trachea|facs / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 6.10e-07 | 196 | 16 | 4 | 8209f2b0f7efebaaf81d642d18a1aee8a9a8dcf6 | |
| ToppCell | 5'-Parenchyma_lung-Epithelial-Alveolar_epithelium-type_II_pneumocyte-AT2-AT2_L.0.1.4.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.10e-07 | 196 | 16 | 4 | 988a3e0688e0a7ba69774497d3b130631bb26c50 | |
| ToppCell | 5'-Adult-LargeIntestine-Mesenchymal-fibroblastic-Stromal_1_(CCL11+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.10e-07 | 196 | 16 | 4 | 2ab9735aa7a7e95dcf6b0bdf0427f7b57f6349ee | |
| ToppCell | nucseq-Mesenchymal-Fibroblastic|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 6.10e-07 | 196 | 16 | 4 | 7d8505dac15fa59935ccf592afc54b04c4c6554f | |
| ToppCell | PND10-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 6.23e-07 | 197 | 16 | 4 | 26475b9e4d6bfc0ae818dea13d139888ed7e92f1 | |
| ToppCell | Fibroblasts-DKK3+_Fibroblasts|World / Immune cells in Rheumatoid Arthritis Joint Synovial Tissues | 6.35e-07 | 198 | 16 | 4 | 4f4632f26a2043c5e4ab89031b4229b5dca1bd48 | |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Mesenchymal-fibroblastic-Stromal_1_(ADAMDEC1+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.35e-07 | 198 | 16 | 4 | 09be07ebfc3e49c3858e9b74605b69cf4fc28b56 | |
| ToppCell | 3'-GW_trimst-1-SmallIntestine-Mesenchymal-fibroblastic-Stromal_2_(NPY+)|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.35e-07 | 198 | 16 | 4 | 4a4566f86c9365a41b4cfd1609eac09bd73b3f34 | |
| ToppCell | 3'-Pediatric_IBD-SmallIntestine-Mesenchymal-fibroblastic-Stromal_1_(CCL11+)|Pediatric_IBD / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.35e-07 | 198 | 16 | 4 | 0f4052a59c6bd89dab637d6ef1214460d6cbcf55 | |
| ToppCell | nucseq-Mesenchymal|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 6.35e-07 | 198 | 16 | 4 | 8f52243ca8b9ba68a75ae411506a3a6de258eb97 | |
| ToppCell | background-Hepatic_Stellate_cells|World / Sample and Cell Type and Tumor Cluster (all cells) | 6.35e-07 | 198 | 16 | 4 | 79f32f965aed6a10c5cb803173e3db7b32e07a91 | |
| ToppCell | Fetal_29-31_weeks|World / Lineage, Cell type, age group and donor | 6.48e-07 | 199 | 16 | 4 | 5b9d355795dd03a22f0961dfd143425c367a4654 | |
| ToppCell | 10x3'2.3-week_17-19-Mesenchymal_fibro-stroma-arteriolar_fibroblast|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 6.48e-07 | 199 | 16 | 4 | 95d95e9b7bd3933188998ae94986213eb0f1e5ea | |
| ToppCell | Bronchial-10x5prime-Stromal-Fibroblastic-Fibro_immune_recruiting|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 6.48e-07 | 199 | 16 | 4 | 0cdbedf09ec72734b86ddab3fec562e066afed92 | |
| ToppCell | 3'-Pediatric_IBD-SmallIntestine-Mesenchymal-fibroblastic-Stromal_1_(ADAMDEC1+)|Pediatric_IBD / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.48e-07 | 199 | 16 | 4 | 6139687a3a5025cb98da4dba0183f95fcae3dc61 | |
| ToppCell | 3'-Pediatric_IBD-SmallIntestine-Mesenchymal-fibroblastic-Stromal_2_(NPY+)|Pediatric_IBD / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.48e-07 | 199 | 16 | 4 | ec74ff85d6b61013b1f785b2fca343759feb7843 | |
| ToppCell | 3'-Child09-12-SmallIntestine-Mesenchymal-fibroblastic-Stromal_1_(ADAMDEC1+)|Child09-12 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.48e-07 | 199 | 16 | 4 | a272c54baf8de59c0f259e6498d144a0de8d8924 | |
| ToppCell | wk_15-18-Mesenchymal-Fibroblast-Adventitial_fibro|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 6.48e-07 | 199 | 16 | 4 | 8de6d7b2067b22cb9b5f01aa56a3803aebc4406d | |
| ToppCell | 3'-GW_trimst-2-LargeIntestine-Mesenchymal|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.48e-07 | 199 | 16 | 4 | c007cd51577e31553395ceaed70ad447e5854546 | |
| ToppCell | 3'-GW_trimst-1-SmallIntestine-Mesenchymal-fibroblastic-Stromal_1_(ADAMDEC1+)|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.48e-07 | 199 | 16 | 4 | a697b3f0760e66bad8ea8d83cf6fea5934692c56 | |
| ToppCell | 3'-Child09-12-SmallIntestine-Mesenchymal-fibroblastic-Stromal_1_(CCL11+)|Child09-12 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.48e-07 | 199 | 16 | 4 | 36883044787a9fb79cf7e83a7da8e34eea83f2f1 | |
| ToppCell | 10x3'2.3-week_12-13-Mesenchymal_fibro-stroma|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 6.61e-07 | 200 | 16 | 4 | 64d2941689d7ca8af54f9ba21c5aeabf719084ef | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-2m-Neuroepithelial-Proteoglycan-expressing_cell|2m / Sample Type, Dataset, Time_group, and Cell type. | 6.61e-07 | 200 | 16 | 4 | eed2bafddcd041ef5fcc4d1d31edb8be4d83ce01 | |
| ToppCell | Parenchymal-10x5prime-Stromal-Myofibroblastic-Muscle_perivascular_immune_recruiting|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 6.61e-07 | 200 | 16 | 4 | 38190e4b32f7469df1da7d130bca6d7b12a3dd06 | |
| ToppCell | 3'-Child04-06-SmallIntestine-Mesenchymal-fibroblastic-Stromal_1_(CCL11+)|Child04-06 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.61e-07 | 200 | 16 | 4 | c0ea7cbc9d5e999530888145ce9e4c232fc874de | |
| ToppCell | Bronchial-NucSeq-Stromal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 6.61e-07 | 200 | 16 | 4 | 389cc775c8419d90fb77cd794376d2160a7bf44e | |
| ToppCell | wk_20-22-Mesenchymal-Fibroblast-intermediate_fibro|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 6.61e-07 | 200 | 16 | 4 | d769723f8fcb37d9b86589e0c41c1d7f16393cfe | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-2m-Neuroepithelial|2m / Sample Type, Dataset, Time_group, and Cell type. | 6.61e-07 | 200 | 16 | 4 | 3da9441c0f1e242f0d195de47ecd4c24dfdca232 | |
| ToppCell | Biopsy_Other_PF-Mesenchymal-PLIN2+_Fibroblasts|Biopsy_Other_PF / Sample group, Lineage and Cell type | 6.61e-07 | 200 | 16 | 4 | 0aa316b71f195ecf17ee897e307f8928a755a637 | |
| Computational | Neighborhood of CDH11 | 2.31e-04 | 25 | 10 | 2 | GNF2_CDH11 | |
| Computational | Lung genes. | 4.53e-04 | 434 | 10 | 4 | MODULE_5 | |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | 9.32e-04 | 50 | 10 | 2 | GAVISH_3CA_MALIGNANT_METAPROGRAM_12_EMT_1 | |
| Computational | ECM and collagens. | 9.74e-04 | 225 | 10 | 3 | MODULE_47 | |
| Computational | Adrenal gland - metabolic genes. | 2.54e-03 | 314 | 10 | 3 | MODULE_19 | |
| Computational | Spinal cord (neuro-development) genes. | 3.75e-03 | 360 | 10 | 3 | MODULE_12 | |
| Computational | Ovary genes. | 3.99e-03 | 368 | 10 | 3 | MODULE_1 | |
| Computational | Immune / stress response genes. | 4.47e-03 | 383 | 10 | 3 | MODULE_33 | |
| Computational | DRG (dorsal root ganglia) genes. | 4.50e-03 | 384 | 10 | 3 | MODULE_2 | |
| Drug | GK-101 | 1.59e-08 | 36 | 18 | 4 | CID000161853 | |
| Drug | Madecassol | 4.37e-08 | 46 | 18 | 4 | CID000108062 | |
| Drug | d-indobufen | 6.15e-08 | 50 | 18 | 4 | CID000044562 | |
| Drug | ridogrel | 7.23e-08 | 52 | 18 | 4 | CID005362391 | |
| Drug | NSC49633 | 7.81e-08 | 53 | 18 | 4 | CID000023340 | |
| Drug | AC1LAKND | 1.48e-07 | 62 | 18 | 4 | CID000470146 | |
| Drug | BAPN | 2.57e-07 | 71 | 18 | 4 | CID000001647 | |
| Drug | malotilate | 2.57e-07 | 71 | 18 | 4 | CID000004006 | |
| Drug | foscarnet | 3.01e-07 | 190 | 18 | 5 | CID000003414 | |
| Drug | AC1NMZ1B | 3.21e-07 | 75 | 18 | 4 | CID005034185 | |
| Drug | strontium ranelate | 3.57e-07 | 77 | 18 | 4 | CID006918182 | |
| Drug | halofuginone lactate | 5.32e-07 | 85 | 18 | 4 | CID000062891 | |
| Drug | 4-hydroxyproline | 7.00e-07 | 91 | 18 | 4 | CID000000825 | |
| Drug | AC1L9HPX | 7.31e-07 | 92 | 18 | 4 | CID000445279 | |
| Drug | ticlopidine | 1.15e-06 | 103 | 18 | 4 | CID000005472 | |
| Drug | AC1L1KMJ | 1.21e-06 | 476 | 18 | 6 | CID000030956 | |
| Drug | hydroxylysine | 1.44e-06 | 109 | 18 | 4 | CID000001029 | |
| Drug | AC1L1C2F | 1.50e-06 | 110 | 18 | 4 | CID000001711 | |
| Drug | PPACK | 1.67e-06 | 113 | 18 | 4 | CID003036757 | |
| Drug | AC1L9732 | 1.73e-06 | 114 | 18 | 4 | CID000439300 | |
| Drug | Tranilast sodium | 1.79e-06 | 115 | 18 | 4 | CID000005527 | |
| Drug | Selara | 2.50e-06 | 125 | 18 | 4 | CID000150310 | |
| Drug | DMSe | 3.10e-06 | 132 | 18 | 4 | CID000020796 | |
| Drug | pirfenidone | 3.70e-06 | 138 | 18 | 4 | CID000040632 | |
| Drug | DL-penicillamine | 3.81e-06 | 139 | 18 | 4 | CID000004727 | |
| Drug | PCR 4099 | 3.81e-06 | 139 | 18 | 4 | CID000002806 | |
| Drug | candesartan cilexetil | 4.51e-06 | 145 | 18 | 4 | CID000002540 | |
| Drug | NC-4 | 5.38e-06 | 44 | 18 | 3 | CID006420119 | |
| Drug | L-lysyl-L-lysyl-L-lysine | 6.99e-06 | 162 | 18 | 4 | CID000072363 | |
| Drug | khellin | 8.66e-06 | 171 | 18 | 4 | CID000003828 | |
| Drug | losartan | 8.81e-06 | 378 | 18 | 5 | CID000003961 | |
| Drug | AC1L1DD6 | 1.04e-05 | 179 | 18 | 4 | CID000002299 | |
| Drug | 12(S)-hydroxyeicosatetraenoic acid | 1.29e-05 | 189 | 18 | 4 | CID000001413 | |
| Drug | Pcme | 1.65e-05 | 8 | 18 | 2 | CID000169849 | |
| Drug | 4-aminoazobenzene | 1.84e-05 | 66 | 18 | 3 | CID000006051 | |
| Drug | dermatan sulfate | 2.33e-05 | 220 | 18 | 4 | CID000032756 | |
| Drug | L-3,4-dehydroproline | 2.49e-05 | 73 | 18 | 3 | CID000094284 | |
| Drug | AC1Q6PCP | 2.78e-05 | 230 | 18 | 4 | CID000005267 | |
| Drug | homocystine | 3.53e-05 | 82 | 18 | 3 | CID000010010 | |
| Drug | prostacyclin sodium salt | 3.85e-05 | 250 | 18 | 4 | CID000000159 | |
| Drug | hyaluronan | 4.69e-05 | 263 | 18 | 4 | CID000024759 | |
| Drug | pyridinoline | 6.21e-05 | 99 | 18 | 3 | CID000105068 | |
| Drug | silibinin | 6.41e-05 | 285 | 18 | 4 | CID000005213 | |
| Drug | gluconate | 6.58e-05 | 287 | 18 | 4 | CID000000604 | |
| Drug | (2s,5s)-5-Carboxymethylproline | 9.32e-05 | 314 | 18 | 4 | CID000447989 | |
| Drug | AC1L18QD | 1.06e-04 | 325 | 18 | 4 | CID000000213 | |
| Drug | Trientine | 1.10e-04 | 120 | 18 | 3 | ctd:D014266 | |
| Drug | 351A | 1.11e-04 | 20 | 18 | 2 | CID000122144 | |
| Drug | colchine | 2.00e-04 | 383 | 18 | 4 | CID000002833 | |
| Drug | fluorocitrate | 2.05e-04 | 27 | 18 | 2 | CID000107647 | |
| Drug | chondroitin sulfate | 2.67e-04 | 413 | 18 | 4 | CID000024766 | |
| Drug | isodesmosine | 3.07e-04 | 33 | 18 | 2 | CID000013811 | |
| Drug | AC1L1IIA | 3.18e-04 | 172 | 18 | 3 | CID000004591 | |
| Drug | Sirius red | 3.46e-04 | 35 | 18 | 2 | CID005486818 | |
| Drug | Y-27632 | 3.51e-04 | 444 | 18 | 4 | CID000005711 | |
| Drug | 3-C-4 | 4.08e-04 | 38 | 18 | 2 | CID000118534 | |
| Drug | AC1MRIIV | 4.30e-04 | 39 | 18 | 2 | CID003518584 | |
| Drug | Idoxuridine [54-42-2]; Up 200; 11.2uM; MCF7; HT_HG-U133A | 4.46e-04 | 193 | 18 | 3 | 1480_UP | |
| Drug | Nilutamide [63612-50-0]; Up 200; 12.6uM; MCF7; HT_HG-U133A | 4.52e-04 | 194 | 18 | 3 | 5362_UP | |
| Drug | Sulfadiazine [68-35-9]; Up 200; 16uM; PC3; HT_HG-U133A | 4.66e-04 | 196 | 18 | 3 | 1810_UP | |
| Drug | Foliosidine [2520-38-9]; Down 200; 13uM; PC3; HT_HG-U133A | 4.73e-04 | 197 | 18 | 3 | 4295_DN | |
| Drug | Gemfibrozil [25812-30-0]; Down 200; 16uM; MCF7; HT_HG-U133A | 4.73e-04 | 197 | 18 | 3 | 2277_DN | |
| Drug | Verteporfin [129497-78-5]; Up 200; 2.8uM; MCF7; HT_HG-U133A | 4.73e-04 | 197 | 18 | 3 | 6817_UP | |
| Drug | 2-propylpentanoic acid; Down 200; 500uM; MCF7; HG-U133A | 4.80e-04 | 198 | 18 | 3 | 347_DN | |
| Drug | Phenformin hydrochloride [834-28-6]; Up 200; 16.6uM; MCF7; HT_HG-U133A | 4.80e-04 | 198 | 18 | 3 | 3622_UP | |
| Drug | Ethisterone [434-03-7]; Up 200; 12.8uM; MCF7; HT_HG-U133A | 4.80e-04 | 198 | 18 | 3 | 3975_UP | |
| Drug | Sulfapyridine [144-83-2]; Up 200; 16uM; PC3; HT_HG-U133A | 4.80e-04 | 198 | 18 | 3 | 7151_UP | |
| Drug | 0225151-0000 [351320-15-5]; Up 200; 10uM; MCF7; HT_HG-U133A | 4.80e-04 | 198 | 18 | 3 | 6384_UP | |
| Drug | Melatonin [73-31-4]; Down 200; 17.2uM; PC3; HT_HG-U133A | 4.94e-04 | 200 | 18 | 3 | 6293_DN | |
| Drug | heptanol | 4.99e-04 | 42 | 18 | 2 | CID000008129 | |
| Drug | PD123177 | 5.23e-04 | 43 | 18 | 2 | CID000114899 | |
| Drug | isocycloheximide | 5.46e-04 | 905 | 18 | 5 | CID000002900 | |
| Drug | gamma-cyhalothrin | 6.25e-04 | 47 | 18 | 2 | CID000443046 | |
| Drug | U1 3 | 7.07e-04 | 50 | 18 | 2 | CID011840989 | |
| Drug | desmosine | 7.94e-04 | 53 | 18 | 2 | CID000025435 | |
| Drug | aspirin | 8.59e-04 | 563 | 18 | 4 | CID000002244 | |
| Drug | trapidil | 9.18e-04 | 57 | 18 | 2 | CID000005531 | |
| Drug | CK 6 | 9.51e-04 | 58 | 18 | 2 | CID000447960 | |
| Drug | AC1Q641C | 1.09e-03 | 62 | 18 | 2 | CID000005005 | |
| Disease | Craniofacial ulnar renal syndrome | 7.23e-07 | 3 | 15 | 2 | C4303860 | |
| Disease | Malpuech facial clefting syndrome | 7.23e-07 | 3 | 15 | 2 | C0796032 | |
| Disease | Bethlem myopathy | 1.45e-06 | 4 | 15 | 2 | cv:C1834674 | |
| Disease | BETHLEM MYOPATHY 1 | 1.45e-06 | 4 | 15 | 2 | C1834674 | |
| Disease | Ullrich congenital muscular dystrophy (is_implicated_in) | 1.45e-06 | 4 | 15 | 2 | DOID:0050558 (is_implicated_in) | |
| Disease | MRNA-decapping enzyme 1A measurement | 1.45e-06 | 4 | 15 | 2 | EFO_0802757 | |
| Disease | Ullrich congenital muscular dystrophy 1 | 1.45e-06 | 4 | 15 | 2 | C0410179 | |
| Disease | Bethlem myopathy (is_implicated_in) | 1.45e-06 | 4 | 15 | 2 | DOID:0050663 (is_implicated_in) | |
| Disease | Ullrich congenital muscular dystrophy | 1.45e-06 | 4 | 15 | 2 | cv:C4551860 | |
| Disease | pulse pressure measurement | 2.36e-06 | 1392 | 15 | 7 | EFO_0005763 | |
| Disease | collectin-11 measurement | 2.41e-06 | 5 | 15 | 2 | EFO_0008088 | |
| Disease | collectin-10 measurement | 8.67e-06 | 9 | 15 | 2 | EFO_0801491 | |
| Disease | protein eva-1 homolog C measurement | 1.08e-05 | 10 | 15 | 2 | EFO_0801942 | |
| Disease | Diaphragmatic Hernia | 1.96e-04 | 41 | 15 | 2 | C0019284 | |
| Disease | non-melanoma skin carcinoma | 3.01e-04 | 265 | 15 | 3 | EFO_0009260 | |
| Disease | response to opioid | 4.34e-04 | 61 | 15 | 2 | EFO_0008541 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| YKGGKGMGGWEGGIR | 366 | P54793 | |
| KGELGDMGDQGNIGK | 76 | Q9Y6Z7 | |
| AGKVGGNGSKKGGME | 161 | Q9Y2H0 | |
| GNGSKKGGMEDGKGR | 166 | Q9Y2H0 | |
| EESYKKVGMEGGGLG | 21 | P43699 | |
| DLGPVGYQGMKGEKG | 291 | P12109 | |
| GYQGMKGEKGSRGEK | 296 | P12109 | |
| GMEDSGGGGTGVKKK | 81 | Q8TD26 | |
| KGYRGQKGAKGNMGE | 261 | P12110 | |
| KYGIEEHGKVKMRGG | 136 | P17302 | |
| GYMGLPGIQGKKGDK | 686 | Q96P44 | |
| AKGAKGYQGQLGEMG | 1256 | Q8IZC6 | |
| EKGDMGDKGQKGSVG | 66 | Q9BWP8 | |
| MRGFKGDRGPKGEKG | 361 | Q6ZMJ2 | |
| GGKKMGSKEEENGQG | 181 | Q9H814 | |
| SGEGQGGYAKEMSKE | 281 | Q13423 | |
| VEIMGKGKNGIGFGK | 86 | Q8N807 | |
| KDEDYLGKVGMLNGG | 931 | Q9Y6Y8 | |
| KMGYIPGKGLGKNED | 121 | P63129 | |
| KMGYIPGKGLGKNED | 121 | P63121 | |
| KMGYIPGKGLGKNED | 121 | P63131 | |
| KMGYIPGKGLGKNED | 121 | Q9Y6I0 | |
| KMGYIPGKGLGKNED | 121 | P63125 | |
| KMGYIPGKGLGKNED | 121 | P10265 | |
| KMGYIPGKGLGKNED | 121 | P63123 | |
| KMGYIPGKGLGKNED | 121 | P63119 | |
| KMGYIPGKGLGKNED | 121 | P63124 | |
| KMGYILGKGLGKNED | 121 | P63120 |